Areas of specialty
My goal is to ensure that you are provided with the most up-to-date diagnostic and treatment options that are available for your situation. This may either be PBS reimbursed treatment, pharmaceutical compassionate access programmes, co-payment programmes or clinical trials. I also work closely with other specialists, such as respiratory physicians, thoracic surgeons and radiation oncologists and your case will often be discussed in a multi-disciplinary setting.
Lung Cancers
Non-small-cell lung cancer
Early stage (Surgery or Radiotherapy)
Neoadjuvant or adjuvant immunotherapy +/- chemotherapy, targeted therapy
Advanced stage (Systemic therapy)
Oncogene driven cancers – i.e., EGFR mutation, ALK rearrangement, ROS-1 fusion, MET exon 14 mutations – Targeted therapy
Non-oncogene driven cancers or oncogene driven cancers i.e., KRAS mutations – Immunotherapy +/- chemotherapy
Small-cell lung cancer
Limited stage (Radiotherapy)
Chemotherapy
Extensive stage (systemic therapy)
Immunotherapy +/- chemotherapy